Dexcom reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.67 0.61 Oct/22
FY2026Q2 Jun/2026 0.70 0.61 0.48 Jul/30
FY2026Q1 Mar/2026 0.56 0.47 0.32 Apr/30
FY2025Q4 Dec/2025 0.68 0.65 0.45 Feb/12
FY2025Q3 Sep/2025 0.61 0.57 0.45 Oct/30




Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Align Technology USD 2.64 0.06 Jun/2026
AtriCure USD 0.18 0.18 Jun/2026
Baxter International USD 0.56 0.2 Jun/2026
Becton, Dickinson and Co. USD 3.23 0.33 Jun/2026
Boston Scientific USD 0.86 0.06 Jun/2026
Cooper Companies USD 1.04 0.38 Mar/2026
Dexcom USD 0.7 0.14 Jun/2026
Edwards Lifesciences USD 0.78 0 Jun/2026
Globus Medical USD 1.34 0.22 Jun/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.66 0.24 Jun/2026
Integra LifeSciences USD 0.56 0.02 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merit Medical Systems USD 1.19 0.33 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Solventum Corp USD 2.55 1.07 Jun/2026
Stryker USD 3.69 1.09 Jun/2026
Tandem Diabetes Care USD -0.31 0.01 Jun/2026
Teleflex USD 1.76 0.37 Jun/2026
West Pharmaceutical Services USD 2.37 0.24 Jun/2026
Zimmer Biomet Holdings USD 2.07 0.02 Jun/2026